A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy

A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopy Laboratory Investigation 97, 1245 (October 2017). doi:10.1038/labinvest.2017.40 Authors: Shubhashish Sarkar, Vsevolod L Popov, Malaney R O'Connell, Heather L Stevenson, Brian S Lee, Robert A Obeid, Gurinder K Luthra & Pomila Singh
Source: Laboratory Investigation - Category: Laboratory Medicine Authors: Source Type: research